DOI:
10.1055/s-00000169
American Journal of Perinatology Reports
LinksClose Window
References
Legendre CM, Licht C, Muus P , et al.
Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome.
N Engl J Med 2013;
368 (23) 2169-2181
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.